| Researchers on the Winthrop P. Rockefeller Most cancers Institute on the College of Arkansas for Medical Sciences (UAMS) have been awarded 5 new grants from the Nationwide Most cancers Institute (NCI) in 2024, totaling $4.6 million.
New grants embrace:
- $3.3 million NCI grant to create a Melanoma Resistance Evolution Atlas, Principal Investigator: Alan Tackett, Ph.D., Winthrop P. Rockefeller Most cancers Institute deputy director
- $421,000 NCI grant to check cancer-evolved resistance mechanism to reinforce adoptive T-cells, Principal Investigators: Tackett and Brian Koss, Ph.D., UAMS assistant professor of biochemistry and molecular biology
- $393,000 NCI grant to check the mechanisms of TH17-DC immunotherapy for ovarian most cancers. Principal Investigator: Martin Cannon, Ph.D., UAMS professor of microbiology and immunology
- $393,000 NCI grant to check SR-A as a therapeutic goal in breast most cancers. Principal Investigators: Steven Put up, Ph.D., UAMS professor of pathology, and Behjatolah Karbassi, Ph.D., UAMS affiliate professor of pathology
- $153,000 NCI grant to check the event of immunocompetent melanoma mind metastases organoids. Principal Investigator: Analiz Rodriguez, M.D., Ph.D., UAMS affiliate professor of neurosurgery
The multimillion-dollar improve in extremely aggressive most cancers analysis funding in lower than three months comes on high of an current $11.5 million COBRE grant awarded to UAMS in March by the Nationwide Institutes of Well being (NIH) to ascertain the Heart for Molecular Interactions in Most cancers.
UAMS has considerably strengthened its most cancers analysis expertise pool with the nationwide recruitment of 24 new most cancers researchers since 2020.
“We’re making great progress in assembly the analysis funding threshold that NCI requires of its designated most cancers facilities,” mentioned Michael Birrer, M.D., Ph.D., director of the Winthrop P. Rockefeller Most cancers Institute and UAMS vice chancellor. “To obtain 5 grants from NCI on this brief period of time is uncommon.”
NCI designation is a extremely aggressive evaluation course of throughout which most cancers facilities should display excellent depth and breadth of high-quality most cancers analysis and therapy. Receiving designation brings substantial advantages, together with the flexibility to entry vital federal analysis funding and provide novel medical trials not accessible to non-designated facilities.
